Reaction

Adrenocortical Insufficiency Acute reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,893 reports · 63 co-occurring drugs

As of the last recalculation, Adrenocortical Insufficiency Acute appears in 1,893 FAERS reports alongside 63 co-occurring drug terms. The strongest observed disproportionality signal is ANTI-ITCH (PRR 86.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Anti-Itch	414	86.6	87.2
Anti-Pruritic	414	86.6	87.2
Antipruritic (Anti-Itch)	414	86.6	87.2
Cool Relief Gel With Aloe	414	86.6	87.2
Drs. Hydrocortisone	414	86.6	87.2
Hydrocortisone Continuous Spray	414	86.6	87.2
Hydrocortisone Spray	414	86.6	87.2
Anti-Itch Cream	414	86.6	87.2
Hydrocortisone Lotion	414	86.6	87.1
Hydrocortisone Cream 1%	414	86.6	87.1
Hydrocortisone Cream 1/2%	414	86.6	87.1
Hydrocortisone 1%	414	86.5	87.1
Hydrocortisone Cream	414	86.2	86.7
Hydrocortisone Acetate	424	82.4	82.8
Hydrocortisone	492	81.5	82.0
Hydrocortisone Sodium Succinate	45	53.9	54.1
Pyrazinamide	25	29.6	29.7
Ipilimumab	104	28.0	28.0
Rifampin	28	21.4	21.4
Zoledronic Acid	69	19.6	19.6
Rifampicin	17	18.6	18.7
Isoniazid	27	18.6	18.6
Somatropin	103	16.2	16.3
Pembrolizumab	132	14.8	14.8
Nivolumab	119	14.4	14.4
Eplerenone	15	13.0	13.0
Mometasone	21	12.7	12.7
Rocuronium Bromide	13	12.2	12.2
Fluticasone Propionate Nasal	32	11.8	11.8
Liothyronine Sodium	8	10.1	10.1
Testosterone	20	9.5	9.5
Ketoconazole Foam	11	8.2	8.2
Ketoconazole Cream, 2%	11	8.2	8.2
Valganciclovir Hydrochloride Powder,	9	8.1	8.2
Lenvatinib	24	8.1	8.1
Ketoconazole	12	7.7	7.7
Dexamethasone Sodium Phosphate	7	7.6	7.6
Clobetasol Propionate Ointment Usp, 0.05%	7	7.5	7.5
Clobetasol Propionate	7	7.5	7.5
Pemetrexed	14	7.2	7.2
Norepinephrine	7	7.2	7.2
Tamsulosin Hydrochloride	13	7.0	7.1
Carboplatin	74	6.6	6.6
Paclitaxel (Aibumin-Bound)	43	5.9	5.9
Lanreotide Acetate	4	5.6	5.6
Paclitaxel	45	5.1	5.1
Brinzolamide	4	5.1	5.1
Mometasone Furoate And Formoterol Fumarate Dihydrate	7	5.0	5.0
Durvalumab	9	4.9	4.9
Abiraterone	6	4.9	4.9
Entecavir	5	4.7	4.7
Dabrafenib	9	4.7	4.7
Pemetrexed Disodium	16	4.6	4.6
Trametinib	10	4.6	4.6
Atezolizumab	15	4.3	4.3
Pazopanib Hydrochloride	10	4.1	4.1
Benralizumab	7	3.9	3.9
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate	3	3.7	3.7
Cortisone Acetate	4	3.6	3.6
Encorafenib	3	3.3	3.3
Abiraterone Acetate	11	3.0	3.0
Enzalutamide	15	2.8	2.8
Droxidopa	4	2.0	2.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.